Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 564-572

  Nakamura, Tatsuji ^a   Hisaka, Akihiro ^a   Sawasaki, Yoshio ^a   Suzuki, Yukiko ^a   Fukami, Takehiro ^a   Ishikawa, Kiyofumi ^a   Yano, Mitsuo ^a   Sugiyama, Yuichi ^b  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BQ 587; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR ANTAGONIST; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG TRANSPORT; DRUG UPTAKE; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; LIVER; MALE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030440896     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ALT, J. M., DEERBERG, F., HACKBARTH, H. J. AND STOLTE, H.: The study of urinary protein excretion in male rats as compared with human proteinuria. Contr. Nephrol. 19: 79-87, 1980.
2. ATSUUMI, S., NAKANO, M., KOIKE, Y., TANAKA, S., FUNABASHI, H., MATSUYAMA, K., NAKANO, M., SAWASAKI, Y., FUNABASHI, K. AND MORISHIMA, H.: Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue. Chem. Pharm. Bull. 40: 3214-3221, 1992.
3. BATTERSHILL, P. E. AND CLISSOLD, S. P.: Octreotide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drug Eval. 38: 658-702, 1989.
4. BAUR, H., KASPEREK, S. AND PFAFF, E.: Criteria of viability of isolated liver cells. Hoppe-Seyler's Z. Physiol. Chem. 356: 827-838, 1975.
5. BERTRAMS, A. AND ZIEGLER, K.: Hepatocellular uptake of peptides by bile acid transporters: relationship of carrier-mediated transport of linear peptides with renin-inhibiting activity to multispecific bile acid carrier. Biochim. Biophys. Acta 1091: 337-348, 1991.
6. BLOM, A., KEULEMANS, K. AND MEIJER, D. K. F.: Transport of dibromosulfophthalein by isolated rat hepatocyte. Biochem. Pharm. 30: 1809-1816, 1981.
7. A receptor antagonist (BQ-123) attenuates the development of hypoxic pulmonary hypertension in vivo. Am. Rev. Respir. Dis. 147: A493, 1993.
8. CHAN, L., CHITTINANDANA, A., SHAPIRO, J. I., SHANLEY, P. F. AND SCHRIER, R. W.: Effect of endothelin-receptor antagonist on ischemic acute renal failure. Am. J. Physiol. 266: F135-F138, 1994.
9. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 52: 825-834, 1992.
10. DEDRICK, R. J., ZAHARKO, D. S. AND LUTZ, R.: Transport and binding of methotrexate in vivo. J. Pharm. Sci. 62: 882-890, 1973.
11. FOGO, A., HELLINGS, S. E., INAGAMI, T. AND KON, V.: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int. 42: 770-774, 1992.
12. FUKAMI, T., NIIYAMA, K., AMANO, Y., HISAKA, A., FUJINO, N., SAWASAKI, Y., IHARA, M. AND ISHIKAWA, K.: Cyclic pentapeptide endothelin A receptor antagonists with attenuated in vivo clearance. Chem. Pharm. Bull. (Tokyo) 44: 609-614, 1996.
13. GREENFIELD, J. C., COOK, K. J. AND O'LEARY, I. A.: Disposition, metabolism and excretion of U-71038, a novel renin inhibitor peptide, in the rat. Drug Metab. Dispos. 17: 518-525, 1989.
14. +/bile acid cotransport system. Proc. Natl. Acad. Sci. USA 88: 10629-10633, 1991.
15. A receptor. Life Sci. 50: 247-255, 1992.
16. A receptor in delayd cerebral vasospasm following subarachnoid hemorrhage. Can. J. Neurol. Sci. 20: S14, 1993a.
17. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem. Biophys. Res. Commun. 195: 969-975, 1993b.
18. +-independent organic anion transporter. Proc. Natl. Acad. Sci. USA 91: 133-137, 1994.
19. KULLAK-UBLIC, G. A., HAGENBUCH, B., STIEGER, B., WOLKOFF, A. W. AND MEIER, P. J.: Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 20: 411-416, 1994.
20. LEE, V. H. L.: Peptide and protein drug delivery: Problems and some solutions. In Peptides: A Target for New Drug Development, ed. by S. R. Bloom and G. Burmnstock, pp. 120-134, IBC Technical Services, London, 1991.
21. LEMAIRE, M., AZRIA, M., DANNECKER, R., MARBACH, P., SCHWEITZER, A. AND MAURE, G.: Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. Drug Metab. Dispos. 17: 699-703, 1989.
22. LIN, J. H., SUGIYAMA, Y., AWAZU, S. AND HANANO, M.: Kinetic studies on the deethylation of ethoxybenzamide: A comparative study with isolated hepatocytes and liver microsomes of rat. Biochem. Pharmacol. 29: 2826-2830, 1980.
23. MARBACH, P., BRINER, U., LEMAIRE, M., SCHWEITZER, A. AND TERASAKI, T.: From somatostatin to sandostatin: Pharmacodynamics and pharmacokinetics. Metabolism 41: 7-10, 1992.
24. MEIER, P. J.: Transport polarity of hepatocytes. Semin. Liver Dis. 8: 293-307, 1988.
25. MEIJER, D. K. F., MOL, W. E. M., MÜLLER, M. AND KURZ, G.: Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J. Pharmacokinet. Biopharm. 18: 35-70, 1990.
26. MINO, N., KOBAYASHI, M., NAKAJIMA, H., AMANO, K., ISHIKAWA, K., WATANABE, K., NISHIKIBE, M., YANO, M. AND IKEMOTO, F.: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur. J. Pharmacol. 221: 77-83, 1992.
27. MIYAUCHI, S., SUGIYAMA, Y., SAWADA, Y., MORITA, K., IGA, T. AND HANANO, M.: Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method. J. Pharmacokinet. Biopharm. 15: 25-38, 1987.
28. NAKAMURA, H., SANO, H., YAMAZAKI, M. AND SUGIYAMA, Y.: Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: Contribution of type I system. J. Pharmacol. Exp. Ther. 269: 1220-1227, 1994.
29. A receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur. J. Pharmacol. Mol. Pharm. 225: 347-350, 1992.
30. A receptor antagonist, in spontaneously hypertensive rats treated with Doca-salt. Eur. J. Pharmacol. 259: 339-342, 1994.
31. PALS, D. T., THAISRIVONGS, S., LAWSON, J. A., KATI, W. M., TURNER, S. R., DEGRAAF, G. L., HARRIS, D. W. AND JOHNSON, G. A.: An orally active inhibitor of renin. Hypertension 8: 1105-1112, 1986.
32. PANG, K. S. AND ROWLAND, M.: Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. J. Pharmacokinet. Biopharm. 5: 625-653, 1977.
33. SEEBERGER, A. AND ZIEGLER, K.: Hepatocellular uptake of peptides-II. Interaction between hydrophilic linear renin-inhibiting peptides and transport systems for endogenous substrates in liver cells. Biochem. Pharmacol. 45: 917-925, 1993.
34. SOGABE, K., NIREI, H., SHOUBO, M., HAMADA, K., NOMOTO, A., HENMI, K., NOTSU, Y. AND ONO, T.: A novel endothelin receptor antagonist: Studies with FR-139317. J. Vasc. Res. 29: 201-202, 1992.
35. SUGIYAMA, Y., KIMURA, S., LIN, J. H., IZUMA, M., AWAZU, S. AND HANANO, M.: Effect of organic anions on the uptake of 1-anilino-8-naphthalene sulfonate by isolated liver cells. J. Pharm. Sci. 72: 871-876, 1983.
36. THAISRIVONGS, S., PALS, D. T., HARRIS, D. W., KATI, W. M. AND TURNER, S. R.: Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo. J. Med. Chem. 29: 2088-2093, 1986.
37. TERASAKI, T., MIZUGUCHI, H., ITOH, C., LEMAIRE, M. AND TSUJI, A.: Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm. Res. (NY) 12: 12-17, 1995.
38. TSUJI, A., TERASAKI, T., TAKANOSU, T., TAMAI, I. AND NAKASHIMA, E.: Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Biochem. Pharmacol. 35: 151-158, 1986.
39. WINKLER, K., KEIDING, S. AND TYGSTRUP, N.: Quantitative aspects of structure and function. In The Liver, ed. by G. Paumgartner and R. Preisig, pp. 144-155, Karger, Basel, 1973.
40. YAMAOKA, K., NAKAGAWA, T. AND UNO, T.: Application of Akaike's infomation criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6: 165-175, 1978.
41. YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T. AND UNO, T.: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4: 879-885, 1981.
42. YAMAZAKI, M., SUZUKI, H., SUGIYAMA, Y. AND HANANO, M.: Uptake of organic anions by isolated rat hepatocytes: a classification in terms of ATP-dependency. J. Hepatol. 14: 41-47, 1992.
43. +-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol. 264: G36-G44, 1993a.
44. YAMAZAKI, M., SUZUKI, H., HANANO, M. AND SUGIYAMA, Y.: Different relationships between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions. Am. J. Physiol. 264: G693-G701, 1993b.
45. YAMAZAKI, M., SUZUKI, H. AND SUGIYAMA, Y.: Recent advance in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm. Res., 13; 497-513, 1996.
46. ZIEGLER, K., LINS, W. AND FRIMMER, M.: Hepatocellular transport of cyclosomatostatins: evidence for a carrier system related to the multispecific bile acid transporter. Biochim. Biophys. Acta 1061: 287-296, 1991.
47. +-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 250: 301-308, 1989.